speb/financial-data huggingface dataset:
ALZN income_statement (quarterly, 2025-07-31) — Net Interest Income: -2483.00
ALZN income_statement (quarterly, 2025-07-31) — Net Non Operating Interest Income Expense: -2483.00
ALZN balance_sheet (quarterly, 2025-07-31) — Net PPE: 397921.00
ALZN cash_flow (quarterly, 2025-07-31) — Net PPE Purchase And Sale: 0.00
ALZN cash_flow (quarterly, 2025-07-31) — Net Preferred Stock Issuance: 4035000.00
ALZN balance_sheet (quarterly, 2025-07-31) — Net Tangible Assets: 5343440.00
ALZN income_statement (quarterly, 2025-07-31) — Normalized EBITDA: -2672516.00
ALZN income_statement (quarterly, 2025-07-31) — Normalized Income: -2702684.00
ALZN cash_flow (quarterly, 2025-07-31) — Operating Cash Flow: -2362786.00
ALZN income_statement (quarterly, 2025-07-31) — Operating Income: -2700201.00
ALZN income_statement (quarterly, 2025-07-31) — Operating Revenue: 0.00
ALZN balance_sheet (quarterly, 2025-07-31) — Ordinary Shares Number: 3139861.00
ALZN income_statement (quarterly, 2025-07-31) — Other Gand A: 435044.00
ALZN balance_sheet (quarterly, 2025-07-31) — Payables And Accrued Expenses: 983311.00
ALZN balance_sheet (quarterly, 2025-07-31) — Preferred Stock: 0.00
ALZN cash_flow (quarterly, 2025-07-31) — Preferred Stock Issuance: 4035000.00
ALZN balance_sheet (quarterly, 2025-07-31) — Prepaid Assets: 307958.00
ALZN income_statement (quarterly, 2025-07-31) — Pretax Income: -2702684.00
ALZN cash_flow (quarterly, 2025-07-31) — Purchase Of PPE: 0.00
ALZN income_statement (quarterly, 2025-07-31) — Reconciled Depreciation: 27685.00
ALZN income_statement (quarterly, 2025-07-31) — Research And Development: 1740867.00
ALZN balance_sheet (quarterly, 2025-07-31) — Retained Earnings: -61237945.00
ALZN income_statement (quarterly, 2025-07-31) — Salaries And Wages: 314582.00
ALZN income_statement (quarterly, 2025-07-31) — Selling And Marketing Expense: 150000.00
ALZN income_statement (quarterly, 2025-07-31) — Selling General And Administration: 959334.00
ALZN balance_sheet (quarterly, 2025-07-31) — Share Issued: 3139861.00
ALZN cash_flow (quarterly, 2025-07-31) — Stock Based Compensation: 42902.00
ALZN balance_sheet (quarterly, 2025-07-31) — Stockholders Equity: 5343440.00
ALZN balance_sheet (quarterly, 2025-07-31) — Tangible Book Value: 5343440.00
ALZN income_statement (quarterly, 2025-07-31) — Tax Effect Of Unusual Items: 0.00
ALZN income_statement (quarterly, 2025-07-31) — Tax Rate For Calcs: 0.00
ALZN balance_sheet (quarterly, 2025-07-31) — Total Assets: 6326751.00
ALZN balance_sheet (quarterly, 2025-07-31) — Total Capitalization: 5343440.00
ALZN balance_sheet (quarterly, 2025-07-31) — Total Equity Gross Minority Interest: 5343440.00
ALZN income_statement (quarterly, 2025-07-31) — Total Expenses: 2700201.00
ALZN balance_sheet (quarterly, 2025-07-31) — Total Liabilities Net Minority Interest: 983311.00
ALZN balance_sheet (quarterly, 2025-07-31) — Total Non Current Assets: 397921.00
ALZN balance_sheet (quarterly, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ALZN income_statement (quarterly, 2025-07-31) — Total Operating Income As Reported: -2700201.00
ALZN balance_sheet (quarterly, 2025-07-31) — Working Capital: 4945519.00
ALZN income_statement (quarterly, 2025-10-31) — +Operating Expense: 998109.00
ALZN income_statement (quarterly, 2025-10-31) — +Total Revenue: 0.00
ALZN balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 717488.00
ALZN balance_sheet (quarterly, 2025-10-31) — Additional Paid In Capital: 66612519.00
ALZN income_statement (quarterly, 2025-10-31) — Basic Average Shares: 3380968.00
ALZN income_statement (quarterly, 2025-10-31) — Basic EPS: -0.30
ALZN cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 5620872.00
ALZN balance_sheet (quarterly, 2025-10-31) — Capital Stock: 380.00
ALZN balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 4449433.00
ALZN balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 4449433.00
ALZN balance_sheet (quarterly, 2025-10-31) — Cash Financial: 4449433.00
ALZN cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: 0.00
ALZN cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Investing Activities: 0.00
ALZN cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: -1171439.00
ALZN cash_flow (quarterly, 2025-10-31) — Change In Payables And Accrued Expense: -265823.00
ALZN cash_flow (quarterly, 2025-10-31) — Change In Prepaid Assets: 35943.00
ALZN cash_flow (quarterly, 2025-10-31) — Change In Working Capital: -229880.00
ALZN cash_flow (quarterly, 2025-10-31) — Changes In Cash: -1171439.00
ALZN balance_sheet (quarterly, 2025-10-31) — Common Stock: 380.00
ALZN balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 4374196.00
ALZN balance_sheet (quarterly, 2025-10-31) — Current Assets: 4721448.00
ALZN balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 717488.00
ALZN cash_flow (quarterly, 2025-10-31) — Depreciation: 27685.00
ALZN cash_flow (quarterly, 2025-10-31) — Depreciation Amortization Depletion: 27685.00
ALZN cash_flow (quarterly, 2025-10-31) — Depreciation And Amortization: 27685.00
ALZN income_statement (quarterly, 2025-10-31) — Diluted Average Shares: 3380968.00
ALZN income_statement (quarterly, 2025-10-31) — Diluted EPS: -0.30
ALZN income_statement (quarterly, 2025-10-31) — Diluted NI Availto Com Stockholders: -1000758.00
ALZN income_statement (quarterly, 2025-10-31) — EBIT: -998109.00
ALZN income_statement (quarterly, 2025-10-31) — EBITDA: -970424.00
ALZN cash_flow (quarterly, 2025-10-31) — End Cash Position: 4449433.00
ALZN cash_flow (quarterly, 2025-10-31) — Financing Cash Flow: 0.00
ALZN cash_flow (quarterly, 2025-10-31) — Free Cash Flow: -1171439.00
ALZN income_statement (quarterly, 2025-10-31) — General And Administrative Expense: 821826.00
ALZN income_statement (quarterly, 2025-10-31) — Insurance And Claims: 58737.00
ALZN income_statement (quarterly, 2025-10-31) — Interest Expense: 2649.00
ALZN income_statement (quarterly, 2025-10-31) — Interest Expense Non Operating: 2649.00
ALZN balance_sheet (quarterly, 2025-10-31) — Invested Capital: 4374196.00
ALZN cash_flow (quarterly, 2025-10-31) — Investing Cash Flow: 0.00
ALZN cash_flow (quarterly, 2025-10-31) — Issuance Of Capital Stock: 0.00
ALZN income_statement (quarterly, 2025-10-31) — Net Income: -1000758.00
ALZN income_statement (quarterly, 2025-10-31) — Net Income Common Stockholders: -1000758.00
ALZN income_statement (quarterly, 2025-10-31) — Net Income Continuous Operations: -1000758.00
ALZN income_statement (quarterly, 2025-10-31) — Net Income From Continuing And Discontinued Operation: -1000758.00
ALZN income_statement (quarterly, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: -1000758.00
ALZN cash_flow (quarterly, 2025-10-31) — Net Income From Continuing Operations: -1000758.00
ALZN income_statement (quarterly, 2025-10-31) — Net Income Including Noncontrolling Interests: -1000758.00
ALZN income_statement (quarterly, 2025-10-31) — Net Interest Income: -2649.00
ALZN income_statement (quarterly, 2025-10-31) — Net Non Operating Interest Income Expense: -2649.00
ALZN balance_sheet (quarterly, 2025-10-31) — Net PPE: 370236.00
ALZN cash_flow (quarterly, 2025-10-31) — Net PPE Purchase And Sale: 0.00
ALZN cash_flow (quarterly, 2025-10-31) — Net Preferred Stock Issuance: 0.00
ALZN balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: 4374196.00
ALZN income_statement (quarterly, 2025-10-31) — Normalized EBITDA: -970424.00
ALZN income_statement (quarterly, 2025-10-31) — Normalized Income: -1000758.00
ALZN cash_flow (quarterly, 2025-10-31) — Operating Cash Flow: -1171439.00
ALZN income_statement (quarterly, 2025-10-31) — Operating Income: -998109.00
ALZN income_statement (quarterly, 2025-10-31) — Operating Revenue: 0.00
ALZN balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 3801604.00
ALZN income_statement (quarterly, 2025-10-31) — Other Gand A: 464043.00
ALZN balance_sheet (quarterly, 2025-10-31) — Payables: 717488.00
ALZN balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 717488.00
ALZN balance_sheet (quarterly, 2025-10-31) — Preferred Stock: 0.00
ALZN cash_flow (quarterly, 2025-10-31) — Preferred Stock Issuance: 0.00
ALZN balance_sheet (quarterly, 2025-10-31) — Prepaid Assets: 272015.00
ALZN income_statement (quarterly, 2025-10-31) — Pretax Income: -1000758.00
ALZN cash_flow (quarterly, 2025-10-31) — Purchase Of PPE: 0.00
ALZN income_statement (quarterly, 2025-10-31) — Reconciled Depreciation: 27685.00
ALZN income_statement (quarterly, 2025-10-31) — Research And Development: 176283.00
ALZN balance_sheet (quarterly, 2025-10-31) — Retained Earnings: -62238703.00
ALZN income_statement (quarterly, 2025-10-31) — Salaries And Wages: 299046.00
ALZN income_statement (quarterly, 2025-10-31) — Selling And Marketing Expense: 0.00
ALZN income_statement (quarterly, 2025-10-31) — Selling General And Administration: 821826.00
ALZN balance_sheet (quarterly, 2025-10-31) — Share Issued: 3801604.00
ALZN cash_flow (quarterly, 2025-10-31) — Stock Based Compensation: 31514.00
ALZN balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: 4374196.00
ALZN balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: 4374196.00
ALZN income_statement (quarterly, 2025-10-31) — Tax Effect Of Unusual Items: 0.00
ALZN income_statement (quarterly, 2025-10-31) — Tax Rate For Calcs: 0.00
ALZN balance_sheet (quarterly, 2025-10-31) — Total Assets: 5091684.00
ALZN balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 4374196.00
ALZN balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: 4374196.00
ALZN income_statement (quarterly, 2025-10-31) — Total Expenses: 998109.00
ALZN balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 717488.00
ALZN balance_sheet (quarterly, 2025-10-31) — Total Non Current Assets: 370236.00
ALZN balance_sheet (quarterly, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ALZN income_statement (quarterly, 2025-10-31) — Total Operating Income As Reported: -998109.00
ALZN balance_sheet (quarterly, 2025-10-31) — Working Capital: 4003960.00
ALZN income_statement (quarterly, 2026-01-31) — +Operating Expense: 2197654.00
ALZN income_statement (quarterly, 2026-01-31) — +Total Revenue: 0.00
ALZN balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 1857328.00
ALZN balance_sheet (quarterly, 2026-01-31) — Additional Paid In Capital: 66621819.00
ALZN income_statement (quarterly, 2026-01-31) — Basic Average Shares: 3804741.00
ALZN income_statement (quarterly, 2026-01-31) — Basic EPS: -0.58
ALZN cash_flow (quarterly, 2026-01-31) — Beginning Cash Position: 4449433.00
ALZN balance_sheet (quarterly, 2026-01-31) — Capital Stock: 380.00
ALZN balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 2713139.00
ALZN balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 2713139.00
ALZN balance_sheet (quarterly, 2026-01-31) — Cash Financial: 2713139.00
ALZN cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Financing Activities: 0.00
ALZN cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Investing Activities: 0.00
ALZN cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Operating Activities: -1736294.00
ALZN cash_flow (quarterly, 2026-01-31) — Change In Payables And Accrued Expense: 1139840.00
ALZN cash_flow (quarterly, 2026-01-31) — Change In Prepaid Assets: -714128.00
ALZN cash_flow (quarterly, 2026-01-31) — Change In Working Capital: 425712.00
ALZN cash_flow (quarterly, 2026-01-31) — Changes In Cash: -1736294.00
ALZN balance_sheet (quarterly, 2026-01-31) — Common Stock: 380.00
ALZN balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 2184505.00
ALZN cash_flow (quarterly, 2026-01-31) — Common Stock Issuance: 0.00
ALZN balance_sheet (quarterly, 2026-01-31) — Current Assets: 3699282.00
ALZN balance_sheet (quarterly, 2026-01-31) — Current Liabilities: 1857328.00
ALZN cash_flow (quarterly, 2026-01-31) — Depreciation: 27685.00
ALZN cash_flow (quarterly, 2026-01-31) — Depreciation Amortization Depletion: 27685.00
ALZN cash_flow (quarterly, 2026-01-31) — Depreciation And Amortization: 27685.00
ALZN income_statement (quarterly, 2026-01-31) — Diluted Average Shares: 3804741.00
ALZN income_statement (quarterly, 2026-01-31) — Diluted EPS: -0.58
ALZN income_statement (quarterly, 2026-01-31) — Diluted NI Availto Com Stockholders: -2198991.00
ALZN income_statement (quarterly, 2026-01-31) — EBIT: -2197654.00
ALZN income_statement (quarterly, 2026-01-31) — EBITDA: -2169969.00
ALZN cash_flow (quarterly, 2026-01-31) — End Cash Position: 2713139.00
ALZN cash_flow (quarterly, 2026-01-31) — Financing Cash Flow: 0.00
ALZN cash_flow (quarterly, 2026-01-31) — Free Cash Flow: -1736294.00
ALZN income_statement (quarterly, 2026-01-31) — General And Administrative Expense: 869025.00
ALZN income_statement (quarterly, 2026-01-31) — Insurance And Claims: 58917.00
ALZN income_statement (quarterly, 2026-01-31) — Interest Expense: 1337.00
ALZN income_statement (quarterly, 2026-01-31) — Interest Expense Non Operating: 1337.00
ALZN balance_sheet (quarterly, 2026-01-31) — Invested Capital: 2184505.00
ALZN cash_flow (quarterly, 2026-01-31) — Investing Cash Flow: 0.00
ALZN cash_flow (quarterly, 2026-01-31) — Issuance Of Capital Stock: 0.00
ALZN cash_flow (quarterly, 2026-01-31) — Net Common Stock Issuance: 0.00
ALZN income_statement (quarterly, 2026-01-31) — Net Income: -2198991.00
ALZN income_statement (quarterly, 2026-01-31) — Net Income Common Stockholders: -2198991.00
ALZN income_statement (quarterly, 2026-01-31) — Net Income Continuous Operations: -2198991.00
ALZN income_statement (quarterly, 2026-01-31) — Net Income From Continuing And Discontinued Operation: -2198991.00
ALZN income_statement (quarterly, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: -2198991.00
ALZN cash_flow (quarterly, 2026-01-31) — Net Income From Continuing Operations: -2198991.00
ALZN income_statement (quarterly, 2026-01-31) — Net Income Including Noncontrolling Interests: -2198991.00
ALZN income_statement (quarterly, 2026-01-31) — Net Interest Income: -1337.00
ALZN income_statement (quarterly, 2026-01-31) — Net Non Operating Interest Income Expense: -1337.00
ALZN balance_sheet (quarterly, 2026-01-31) — Net PPE: 342551.00
ALZN cash_flow (quarterly, 2026-01-31) — Net PPE Purchase And Sale: 0.00
ALZN cash_flow (quarterly, 2026-01-31) — Net Preferred Stock Issuance: 0.00
ALZN balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: 2184505.00
ALZN income_statement (quarterly, 2026-01-31) — Normalized EBITDA: -2169969.00
ALZN income_statement (quarterly, 2026-01-31) — Normalized Income: -2198991.00
ALZN cash_flow (quarterly, 2026-01-31) — Operating Cash Flow: -1736294.00
ALZN income_statement (quarterly, 2026-01-31) — Operating Income: -2197654.00
ALZN income_statement (quarterly, 2026-01-31) — Operating Revenue: 0.00
ALZN balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 3804741.00
ALZN income_statement (quarterly, 2026-01-31) — Other Gand A: 447332.00
ALZN balance_sheet (quarterly, 2026-01-31) — Payables: 1857328.00
ALZN balance_sheet (quarterly, 2026-01-31) — Payables And Accrued Expenses: 1857328.00
ALZN balance_sheet (quarterly, 2026-01-31) — Preferred Stock: 0.00
ALZN cash_flow (quarterly, 2026-01-31) — Preferred Stock Issuance: 0.00
ALZN balance_sheet (quarterly, 2026-01-31) — Prepaid Assets: 986143.00
ALZN income_statement (quarterly, 2026-01-31) — Pretax Income: -2198991.00
ALZN cash_flow (quarterly, 2026-01-31) — Purchase Of PPE: 0.00
ALZN income_statement (quarterly, 2026-01-31) — Reconciled Depreciation: 27685.00
ALZN income_statement (quarterly, 2026-01-31) — Research And Development: 1278629.00
ALZN balance_sheet (quarterly, 2026-01-31) — Retained Earnings: -64437694.00
ALZN income_statement (quarterly, 2026-01-31) — Salaries And Wages: 362776.00
ALZN income_statement (quarterly, 2026-01-31) — Selling And Marketing Expense: 50000.00
ALZN income_statement (quarterly, 2026-01-31) — Selling General And Administration: 919025.00
ALZN balance_sheet (quarterly, 2026-01-31) — Share Issued: 3804741.00
ALZN cash_flow (quarterly, 2026-01-31) — Stock Based Compensation: 9300.00
ALZN balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: 2184505.00
ALZN balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: 2184505.00
ALZN income_statement (quarterly, 2026-01-31) — Tax Effect Of Unusual Items: 0.00
ALZN income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.00
ALZN balance_sheet (quarterly, 2026-01-31) — Total Assets: 4041833.00
ALZN balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 2184505.00
ALZN balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 2184505.00
ALZN income_statement (quarterly, 2026-01-31) — Total Expenses: 2197654.00
ALZN balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 1857328.00
ALZN balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 342551.00
ALZN balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ALZN income_statement (quarterly, 2026-01-31) — Total Operating Income As Reported: -2197654.00
ALZN balance_sheet (quarterly, 2026-01-31) — Working Capital: 1841954.00
ALZN income_statement (annual, 2026-04-30) — +Operating Expense: 8766841.00
ALZN income_statement (quarterly, 2026-04-30) — +Operating Expense: 2870877.00
ALZN income_statement (annual, 2026-04-30) — +Total Revenue: 0.00
ALZN income_statement (quarterly, 2026-04-30) — +Total Revenue: 0.00
ALZN balance_sheet (annual, 2026-04-30) — Accounts Payable: 1346152.00
ALZN balance_sheet (quarterly, 2026-04-30) — Accounts Payable: 1346152.00
ALZN balance_sheet (annual, 2026-04-30) — Additional Paid In Capital: 68040429.00
ALZN balance_sheet (quarterly, 2026-04-30) — Additional Paid In Capital: 68040429.00
ALZN income_statement (annual, 2026-04-30) — Basic Average Shares: 3337143.00
ALZN income_statement (annual, 2026-04-30) — Basic EPS: -2.63
ALZN cash_flow (annual, 2026-04-30) — Beginning Cash Position: 3948658.00
ALZN cash_flow (quarterly, 2026-04-30) — Beginning Cash Position: 2713139.00
ALZN balance_sheet (annual, 2026-04-30) — Capital Stock: 425.00
ALZN balance_sheet (quarterly, 2026-04-30) — Capital Stock: 425.00
ALZN balance_sheet (annual, 2026-04-30) — Cash And Cash Equivalents: 710689.00
ALZN balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 710689.00
ALZN balance_sheet (annual, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 710689.00
ALZN balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 710689.00
ALZN balance_sheet (annual, 2026-04-30) — Cash Financial: 710689.00
ALZN balance_sheet (quarterly, 2026-04-30) — Cash Financial: 710689.00
ALZN cash_flow (annual, 2026-04-30) — Cash Flow From Continuing Financing Activities: 4829844.00
ALZN cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Financing Activities: 794844.00
ALZN cash_flow (annual, 2026-04-30) — Cash Flow From Continuing Investing Activities: 0.00
ALZN cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Investing Activities: 0.00
ALZN cash_flow (annual, 2026-04-30) — Cash Flow From Continuing Operating Activities: -8067813.00
ALZN cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Operating Activities: -2797294.00
ALZN cash_flow (annual, 2026-04-30) — Change In Payables And Accrued Expense: 711391.00
ALZN cash_flow (quarterly, 2026-04-30) — Change In Payables And Accrued Expense: -511176.00
ALZN cash_flow (annual, 2026-04-30) — Change In Prepaid Assets: -825089.00
ALZN cash_flow (quarterly, 2026-04-30) — Change In Prepaid Assets: -67665.00
ALZN cash_flow (annual, 2026-04-30) — Change In Working Capital: -113698.00
ALZN cash_flow (quarterly, 2026-04-30) — Change In Working Capital: -578841.00
ALZN cash_flow (annual, 2026-04-30) — Changes In Cash: -3237969.00
ALZN cash_flow (quarterly, 2026-04-30) — Changes In Cash: -2002450.00
ALZN balance_sheet (annual, 2026-04-30) — Common Stock: 425.00
ALZN balance_sheet (quarterly, 2026-04-30) — Common Stock: 425.00
ALZN balance_sheet (annual, 2026-04-30) — Common Stock Equity: 733211.00
ALZN balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: 733211.00
ALZN cash_flow (annual, 2026-04-30) — Common Stock Issuance: 794844.00
ALZN cash_flow (quarterly, 2026-04-30) — Common Stock Issuance: 794844.00
ALZN balance_sheet (annual, 2026-04-30) — Current Assets: 1764497.00
ALZN balance_sheet (quarterly, 2026-04-30) — Current Assets: 1764497.00
ALZN balance_sheet (annual, 2026-04-30) — Current Liabilities: 1346152.00
ALZN balance_sheet (quarterly, 2026-04-30) — Current Liabilities: 1346152.00
ALZN cash_flow (annual, 2026-04-30) — Depreciation: 110740.00
ALZN cash_flow (quarterly, 2026-04-30) — Depreciation: 27685.00
ALZN cash_flow (annual, 2026-04-30) — Depreciation Amortization Depletion: 110740.00
ALZN cash_flow (quarterly, 2026-04-30) — Depreciation Amortization Depletion: 27685.00
ALZN cash_flow (annual, 2026-04-30) — Depreciation And Amortization: 110740.00
ALZN cash_flow (quarterly, 2026-04-30) — Depreciation And Amortization: 27685.00
ALZN income_statement (annual, 2026-04-30) — Diluted Average Shares: 3337143.00
ALZN income_statement (annual, 2026-04-30) — Diluted EPS: -2.63
ALZN income_statement (annual, 2026-04-30) — Diluted NI Availto Com Stockholders: -8772382.00
ALZN income_statement (quarterly, 2026-04-30) — Diluted NI Availto Com Stockholders: -2869949.00
ALZN income_statement (annual, 2026-04-30) — EBIT: -8765763.00
ALZN income_statement (quarterly, 2026-04-30) — EBIT: -2869799.00
ALZN income_statement (annual, 2026-04-30) — EBITDA: -8655023.00
ALZN income_statement (quarterly, 2026-04-30) — EBITDA: -2842114.00
ALZN cash_flow (annual, 2026-04-30) — End Cash Position: 710689.00
ALZN cash_flow (quarterly, 2026-04-30) — End Cash Position: 710689.00
ALZN cash_flow (annual, 2026-04-30) — Financing Cash Flow: 4829844.00
ALZN cash_flow (quarterly, 2026-04-30) — Financing Cash Flow: 794844.00
ALZN cash_flow (annual, 2026-04-30) — Free Cash Flow: -8067813.00
ALZN cash_flow (quarterly, 2026-04-30) — Free Cash Flow: -2797294.00
ALZN income_statement (annual, 2026-04-30) — General And Administrative Expense: 4712056.00
ALZN income_statement (quarterly, 2026-04-30) — General And Administrative Expense: 2211871.00
ALZN income_statement (annual, 2026-04-30) — Insurance And Claims: 236279.00
ALZN income_statement (quarterly, 2026-04-30) — Insurance And Claims: 58917.00
ALZN income_statement (annual, 2026-04-30) — Interest Expense: 6619.00
ALZN income_statement (quarterly, 2026-04-30) — Interest Expense: 150.00
ALZN income_statement (annual, 2026-04-30) — Interest Expense Non Operating: 6619.00
ALZN income_statement (quarterly, 2026-04-30) — Interest Expense Non Operating: 150.00
ALZN income_statement (annual, 2026-04-30) — Interest Income: 1078.00
ALZN income_statement (annual, 2026-04-30) — Interest Income Non Operating: 1078.00
ALZN balance_sheet (annual, 2026-04-30) — Invested Capital: 733211.00
ALZN balance_sheet (quarterly, 2026-04-30) — Invested Capital: 733211.00
ALZN cash_flow (annual, 2026-04-30) — Investing Cash Flow: 0.00
ALZN cash_flow (quarterly, 2026-04-30) — Investing Cash Flow: 0.00
ALZN cash_flow (annual, 2026-04-30) — Issuance Of Capital Stock: 4829844.00
ALZN cash_flow (quarterly, 2026-04-30) — Issuance Of Capital Stock: 794844.00
ALZN cash_flow (annual, 2026-04-30) — Net Common Stock Issuance: 794844.00
ALZN cash_flow (quarterly, 2026-04-30) — Net Common Stock Issuance: 794844.00
ALZN income_statement (annual, 2026-04-30) — Net Income: -8772382.00
ALZN income_statement (quarterly, 2026-04-30) — Net Income: -2869949.00
ALZN income_statement (annual, 2026-04-30) — Net Income Common Stockholders: -8772382.00
ALZN income_statement (quarterly, 2026-04-30) — Net Income Common Stockholders: -2869949.00
ALZN income_statement (annual, 2026-04-30) — Net Income Continuous Operations: -8772382.00
ALZN income_statement (quarterly, 2026-04-30) — Net Income Continuous Operations: -2869949.00
ALZN income_statement (annual, 2026-04-30) — Net Income From Continuing And Discontinued Operation: -8772382.00
ALZN income_statement (quarterly, 2026-04-30) — Net Income From Continuing And Discontinued Operation: -2869949.00
ALZN income_statement (annual, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: -8772382.00
ALZN income_statement (quarterly, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: -2869949.00
ALZN cash_flow (annual, 2026-04-30) — Net Income From Continuing Operations: -8772382.00
ALZN cash_flow (quarterly, 2026-04-30) — Net Income From Continuing Operations: -2869949.00
ALZN income_statement (annual, 2026-04-30) — Net Income Including Noncontrolling Interests: -8772382.00
ALZN income_statement (quarterly, 2026-04-30) — Net Income Including Noncontrolling Interests: -2869949.00
ALZN income_statement (annual, 2026-04-30) — Net Interest Income: -5541.00
ALZN income_statement (quarterly, 2026-04-30) — Net Interest Income: 928.00
ALZN income_statement (annual, 2026-04-30) — Net Non Operating Interest Income Expense: -5541.00
ALZN income_statement (quarterly, 2026-04-30) — Net Non Operating Interest Income Expense: 928.00
ALZN balance_sheet (annual, 2026-04-30) — Net PPE: 314866.00
ALZN balance_sheet (quarterly, 2026-04-30) — Net PPE: 314866.00
ALZN cash_flow (annual, 2026-04-30) — Net PPE Purchase And Sale: 0.00
ALZN cash_flow (quarterly, 2026-04-30) — Net PPE Purchase And Sale: 0.00
ALZN cash_flow (annual, 2026-04-30) — Net Preferred Stock Issuance: 4035000.00
ALZN cash_flow (quarterly, 2026-04-30) — Net Preferred Stock Issuance: 0.00
ALZN balance_sheet (annual, 2026-04-30) — Net Tangible Assets: 733211.00
ALZN balance_sheet (quarterly, 2026-04-30) — Net Tangible Assets: 733211.00
ALZN income_statement (annual, 2026-04-30) — Normalized EBITDA: -8655023.00
ALZN income_statement (quarterly, 2026-04-30) — Normalized EBITDA: -2842114.00
ALZN income_statement (annual, 2026-04-30) — Normalized Income: -8772382.00
ALZN income_statement (quarterly, 2026-04-30) — Normalized Income: -2869949.00
ALZN cash_flow (annual, 2026-04-30) — Operating Cash Flow: -8067813.00
ALZN cash_flow (quarterly, 2026-04-30) — Operating Cash Flow: -2797294.00
ALZN income_statement (annual, 2026-04-30) — Operating Income: -8766841.00
ALZN income_statement (quarterly, 2026-04-30) — Operating Income: -2870877.00
ALZN income_statement (annual, 2026-04-30) — Operating Revenue: 0.00
ALZN income_statement (quarterly, 2026-04-30) — Operating Revenue: 0.00
ALZN balance_sheet (annual, 2026-04-30) — Ordinary Shares Number: 3804741.00
ALZN balance_sheet (quarterly, 2026-04-30) — Ordinary Shares Number: 3804741.00
ALZN income_statement (annual, 2026-04-30) — Other Gand A: 2645535.00
ALZN income_statement (quarterly, 2026-04-30) — Other Gand A: 1299116.00
ALZN balance_sheet (annual, 2026-04-30) — Payables: 1346152.00
ALZN balance_sheet (quarterly, 2026-04-30) — Payables: 1346152.00
ALZN balance_sheet (annual, 2026-04-30) — Payables And Accrued Expenses: 1346152.00
ALZN balance_sheet (quarterly, 2026-04-30) — Payables And Accrued Expenses: 1346152.00
ALZN balance_sheet (annual, 2026-04-30) — Preferred Stock: 0.00
ALZN balance_sheet (quarterly, 2026-04-30) — Preferred Stock: 0.00
ALZN cash_flow (annual, 2026-04-30) — Preferred Stock Issuance: 4035000.00
ALZN cash_flow (quarterly, 2026-04-30) — Preferred Stock Issuance: 0.00
ALZN balance_sheet (annual, 2026-04-30) — Prepaid Assets: 1053808.00
ALZN balance_sheet (quarterly, 2026-04-30) — Prepaid Assets: 1053808.00
ALZN income_statement (annual, 2026-04-30) — Pretax Income: -8772382.00
ALZN income_statement (quarterly, 2026-04-30) — Pretax Income: -2869949.00
ALZN cash_flow (annual, 2026-04-30) — Proceeds From Stock Option Exercised: 0.00
ALZN cash_flow (annual, 2026-04-30) — Purchase Of PPE: 0.00
ALZN cash_flow (quarterly, 2026-04-30) — Purchase Of PPE: 0.00
ALZN income_statement (annual, 2026-04-30) — Reconciled Depreciation: 110740.00
ALZN income_statement (quarterly, 2026-04-30) — Reconciled Depreciation: 27685.00
ALZN income_statement (annual, 2026-04-30) — Research And Development: 3629785.00
ALZN income_statement (quarterly, 2026-04-30) — Research And Development: 434006.00
ALZN balance_sheet (annual, 2026-04-30) — Retained Earnings: -67307643.00
ALZN balance_sheet (quarterly, 2026-04-30) — Retained Earnings: -67307643.00
ALZN income_statement (annual, 2026-04-30) — Salaries And Wages: 1830242.00
ALZN income_statement (quarterly, 2026-04-30) — Salaries And Wages: 853838.00
ALZN income_statement (annual, 2026-04-30) — Selling And Marketing Expense: 425000.00
ALZN income_statement (quarterly, 2026-04-30) — Selling And Marketing Expense: 225000.00
ALZN income_statement (annual, 2026-04-30) — Selling General And Administration: 5137056.00
ALZN income_statement (quarterly, 2026-04-30) — Selling General And Administration: 2436871.00
ALZN balance_sheet (annual, 2026-04-30) — Share Issued: 3804741.00
ALZN balance_sheet (quarterly, 2026-04-30) — Share Issued: 3804741.00
ALZN cash_flow (annual, 2026-04-30) — Stock Based Compensation: 707527.00
ALZN cash_flow (quarterly, 2026-04-30) — Stock Based Compensation: 623811.00
ALZN balance_sheet (annual, 2026-04-30) — Stockholders Equity: 733211.00
ALZN balance_sheet (quarterly, 2026-04-30) — Stockholders Equity: 733211.00
ALZN balance_sheet (annual, 2026-04-30) — Tangible Book Value: 733211.00
ALZN balance_sheet (quarterly, 2026-04-30) — Tangible Book Value: 733211.00
ALZN income_statement (annual, 2026-04-30) — Tax Effect Of Unusual Items: 0.00
ALZN income_statement (quarterly, 2026-04-30) — Tax Effect Of Unusual Items: 0.00
ALZN income_statement (annual, 2026-04-30) — Tax Rate For Calcs: 0.00
ALZN income_statement (quarterly, 2026-04-30) — Tax Rate For Calcs: 0.00
ALZN balance_sheet (annual, 2026-04-30) — Total Assets: 2079363.00
ALZN balance_sheet (quarterly, 2026-04-30) — Total Assets: 2079363.00
ALZN balance_sheet (annual, 2026-04-30) — Total Capitalization: 733211.00
ALZN balance_sheet (quarterly, 2026-04-30) — Total Capitalization: 733211.00
ALZN balance_sheet (annual, 2026-04-30) — Total Equity Gross Minority Interest: 733211.00
ALZN balance_sheet (quarterly, 2026-04-30) — Total Equity Gross Minority Interest: 733211.00
ALZN income_statement (annual, 2026-04-30) — Total Expenses: 8766841.00
ALZN income_statement (quarterly, 2026-04-30) — Total Expenses: 2870877.00
ALZN balance_sheet (annual, 2026-04-30) — Total Liabilities Net Minority Interest: 1346152.00
ALZN balance_sheet (quarterly, 2026-04-30) — Total Liabilities Net Minority Interest: 1346152.00
ALZN balance_sheet (annual, 2026-04-30) — Total Non Current Assets: 314866.00
ALZN balance_sheet (quarterly, 2026-04-30) — Total Non Current Assets: 314866.00
ALZN balance_sheet (annual, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 0.00
ALZN balance_sheet (quarterly, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 0.00
ALZN income_statement (annual, 2026-04-30) — Total Operating Income As Reported: -8766841.00
ALZN income_statement (quarterly, 2026-04-30) — Total Operating Income As Reported: -2870877.00
ALZN balance_sheet (annual, 2026-04-30) — Working Capital: 418345.00
ALZN balance_sheet (quarterly, 2026-04-30) — Working Capital: 418345.00
AM cash_flow (annual, 2021-12-31) — Change In Income Tax Payable: 0.00
AM cash_flow (annual, 2021-12-31) — Change In Tax Payable: 0.00
AM cash_flow (annual, 2021-12-31) — Changes In Cash: -640000.00
AM cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 16311000.00
AM balance_sheet (annual, 2021-12-31) — Investmentsin Associatesat Cost: 696009000.00
AM cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: -66300000.00
AM balance_sheet (annual, 2021-12-31) — Non Current Deferred Assets: 0.00
AM balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Assets: 0.00
AM balance_sheet (annual, 2021-12-31) — Other Payable: 23592000.00
AM balance_sheet (annual, 2021-12-31) — Other Receivables: 747000.00
AM income_statement (annual, 2021-12-31) — Other Special Charges: 21757000.00
AM income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 0.00
AM income_statement (annual, 2021-12-31) — Salaries And Wages: 13529000.00
AM cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
AM cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 1013400000.00
AM cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -66300000.00
AM income_statement (annual, 2022-12-31) — +Operating Expense: 67052000.00
AM income_statement (annual, 2022-12-31) — +Total Revenue: 990657000.00
AM balance_sheet (annual, 2022-12-31) — Accounts Payable: 28301000.00
AM balance_sheet (annual, 2022-12-31) — Accounts Receivable: 86727000.00
AM balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -397269000.00
AM balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 2104740000.00
AM cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 70672000.00
AM cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 70672000.00
AM cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 3702000.00
AM income_statement (annual, 2022-12-31) — Basic Average Shares: 478232000.00
AM income_statement (annual, 2022-12-31) — Basic EPS: 0.68
AM cash_flow (annual, 2022-12-31) — Beginning Cash Position: 0.00
AM cash_flow (annual, 2022-12-31) — Capital Expenditure: -515650000.00
AM balance_sheet (annual, 2022-12-31) — Capital Stock: 4785000.00
AM balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 0.00
AM balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 0.00
AM cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -433375000.00
AM cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -205778000.00
AM cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -493826000.00
AM cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 699604000.00
AM cash_flow (annual, 2022-12-31) — Change In Account Payable: 8755000.00
AM cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -747000.00
AM cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -313000.00
AM cash_flow (annual, 2022-12-31) — Change In Payable: 8755000.00
AM cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 8008000.00
AM cash_flow (annual, 2022-12-31) — Change In Receivables: -2631000.00
AM cash_flow (annual, 2022-12-31) — Change In Working Capital: 5064000.00
AM cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -2631000.00
AM balance_sheet (annual, 2022-12-31) — Common Stock: 4785000.00
AM cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -432825000.00
AM balance_sheet (annual, 2022-12-31) — Common Stock Equity: 2192318000.00
AM cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
AM balance_sheet (annual, 2022-12-31) — Construction In Progress: 158977000.00
AM income_statement (annual, 2022-12-31) — Cost Of Revenue: 382688000.00
AM balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 67054000.00
AM balance_sheet (annual, 2022-12-31) — Current Assets: 88993000.00
AM balance_sheet (annual, 2022-12-31) — Current Liabilities: 102077000.00
AM cash_flow (annual, 2022-12-31) — Deferred Income Tax: 117494000.00
AM cash_flow (annual, 2022-12-31) — Deferred Tax: 117494000.00
AM cash_flow (annual, 2022-12-31) — Depreciation: 131762000.00
AM cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 202434000.00
AM cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 202434000.00
AM income_statement (annual, 2022-12-31) — Diluted Average Shares: 480300000.00
AM income_statement (annual, 2022-12-31) — Diluted EPS: 0.68
AM income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 325692000.00
AM cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 120460000.00
AM income_statement (annual, 2022-12-31) — EBIT: 633684000.00
AM income_statement (annual, 2022-12-31) — EBITDA: 836118000.00
AM income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 94218000.00
AM cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -94218000.00
AM cash_flow (annual, 2022-12-31) — End Cash Position: 0.00
AM cash_flow (annual, 2022-12-31) — Financing Cash Flow: -205778000.00
AM cash_flow (annual, 2022-12-31) — Free Cash Flow: 183954000.00
AM income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 2251000.00
AM income_statement (annual, 2022-12-31) — General And Administrative Expense: 62125000.00
AM balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1286103000.00
AM balance_sheet (annual, 2022-12-31) — Gross PPE: 4148700000.00
AM income_statement (annual, 2022-12-31) — Gross Profit: 607969000.00
AM income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 3702000.00
AM cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 0.00
AM income_statement (annual, 2022-12-31) — Interest Expense: 189948000.00
AM income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 189948000.00
AM cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 183079000.00
AM balance_sheet (annual, 2022-12-31) — Interest Payable: 37947000.00
AM balance_sheet (annual, 2022-12-31) — Invested Capital: 5553600000.00
AM cash_flow (annual, 2022-12-31) — Investing Cash Flow: -493826000.00
AM balance_sheet (annual, 2022-12-31) — Investments And Advances: 652767000.00
AM cash_flow (annual, 2022-12-31) — Issuance Of Debt: 1269300000.00
AM balance_sheet (annual, 2022-12-31) — Land And Improvements: 31668000.00
AM balance_sheet (annual, 2022-12-31) — Long Term Debt: 3361282000.00
AM balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 3361282000.00
AM cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 1269300000.00
AM cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -1034500000.00
AM balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 652767000.00
AM balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 3287029000.00
AM cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 17000000.00
AM cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
AM balance_sheet (annual, 2022-12-31) — Net Debt: 3361282000.00
AM income_statement (annual, 2022-12-31) — Net Income: 326242000.00
AM income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 325692000.00
AM income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 326242000.00
AM income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 326242000.00
AM income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 326242000.00
AM cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 326242000.00
AM income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 652484000.00
AM income_statement (annual, 2022-12-31) — Net Interest Income: -189948000.00
AM cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 234800000.00
AM cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 234800000.00
AM income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -189948000.00
AM cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -7203000.00
AM cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 4824000.00
AM balance_sheet (annual, 2022-12-31) — Net PPE: 3751431000.00
AM cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -515650000.00
AM cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 234800000.00
AM balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 906215000.00
AM balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 131215000.00
AM balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 131215000.00
AM income_statement (annual, 2022-12-31) — Normalized EBITDA: 837569000.00
AM income_statement (annual, 2022-12-31) — Normalized Income: 327308799.05
AM cash_flow (annual, 2022-12-31) — Operating Cash Flow: 699604000.00
AM cash_flow (annual, 2022-12-31) — Operating Gains Losses: -96469000.00
AM income_statement (annual, 2022-12-31) — Operating Income: 540917000.00
AM income_statement (annual, 2022-12-31) — Operating Revenue: 990657000.00
AM balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 478497000.00
AM balance_sheet (annual, 2022-12-31) — Other Current Assets: 1326000.00
AM balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 1061000.00
AM income_statement (annual, 2022-12-31) — Other Gand A: 62125000.00
AM income_statement (annual, 2022-12-31) — Other Income Expense: 92767000.00
AM balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 1286103000.00
AM cash_flow (annual, 2022-12-31) — Other Non Cash Items: 1023000.00
AM balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 12026000.00
AM balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 4428000.00
AM income_statement (annual, 2022-12-31) — Other Operating Expenses: 4927000.00
AM balance_sheet (annual, 2022-12-31) — Other Payable: 22865000.00
AM balance_sheet (annual, 2022-12-31) — Other Properties: 671026000.00
AM balance_sheet (annual, 2022-12-31) — Other Receivables: 575000.00
AM balance_sheet (annual, 2022-12-31) — Payables: 33962000.00
AM balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 101016000.00
AM balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
AM cash_flow (annual, 2022-12-31) — Preferred Stock Dividend Paid: -550000.00
AM income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 550000.00
AM income_statement (annual, 2022-12-31) — Pretax Income: 443736000.00
AM cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
AM cash_flow (annual, 2022-12-31) — Purchase Of PPE: -515650000.00
AM balance_sheet (annual, 2022-12-31) — Receivables: 87667000.00
AM income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 382688000.00
AM income_statement (annual, 2022-12-31) — Reconciled Depreciation: 202434000.00
AM cash_flow (annual, 2022-12-31) — Repayment Of Debt: -1034500000.00
AM cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
AM balance_sheet (annual, 2022-12-31) — Retained Earnings: 82793000.00
AM income_statement (annual, 2022-12-31) — Salaries And Wages: 19654000.00
AM cash_flow (annual, 2022-12-31) — Sale Of Business: 17000000.00
AM income_statement (annual, 2022-12-31) — Selling General And Administration: 62125000.00
AM balance_sheet (annual, 2022-12-31) — Share Issued: 478497000.00
AM cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 1269300000.00
AM cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -1034500000.00
AM income_statement (annual, 2022-12-31) — Special Income Charges: -1451000.00
AM cash_flow (annual, 2022-12-31) — Stock Based Compensation: 19654000.00
AM balance_sheet (annual, 2022-12-31) — Stockholders Equity: 2192318000.00
AM balance_sheet (annual, 2022-12-31) — Tangible Book Value: 906215000.00
AM income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -384200.95
AM income_statement (annual, 2022-12-31) — Tax Provision: 117494000.00
AM income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
AM balance_sheet (annual, 2022-12-31) — Taxes Receivable: 940000.00
AM balance_sheet (annual, 2022-12-31) — Total Assets: 5791320000.00
AM balance_sheet (annual, 2022-12-31) — Total Capitalization: 5553600000.00
AM balance_sheet (annual, 2022-12-31) — Total Debt: 3361282000.00
AM balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 2192318000.00
AM income_statement (annual, 2022-12-31) — Total Expenses: 449740000.00
AM balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 3599002000.00
AM balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 5702327000.00
AM balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 3496925000.00
AM income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 539466000.00
AM balance_sheet (annual, 2022-12-31) — Total Tax Payable: 5661000.00
AM income_statement (annual, 2022-12-31) — Total Unusual Items: -1451000.00
AM income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -1451000.00
AM balance_sheet (annual, 2022-12-31) — Working Capital: -13084000.00
AM income_statement (annual, 2023-12-31) — +Operating Expense: 80539000.00
AM income_statement (annual, 2023-12-31) — +Total Revenue: 1112443000.00
AM balance_sheet (annual, 2023-12-31) — Accounts Payable: 14956000.00
AM balance_sheet (annual, 2023-12-31) — Accounts Receivable: 89562000.00
AM balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -532579000.00
AM balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 2046487000.00
AM cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 70672000.00
AM cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 70672000.00
AM cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 146000.00
AM income_statement (annual, 2023-12-31) — Basic Average Shares: 479378000.00
AM income_statement (annual, 2023-12-31) — Basic EPS: 0.77
AM cash_flow (annual, 2023-12-31) — Beginning Cash Position: 0.00
AM cash_flow (annual, 2023-12-31) — Capital Expenditure: -183999000.00
AM balance_sheet (annual, 2023-12-31) — Capital Stock: 4797000.00
AM balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 66000.00
AM balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 66000.00
AM cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -435396000.00
AM cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -595791000.00
AM cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -183206000.00
AM cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 779063000.00
AM cash_flow (annual, 2023-12-31) — Change In Account Payable: -9033000.00
AM cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 8251000.00
AM cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: 0.00
AM cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -2041000.00
AM cash_flow (annual, 2023-12-31) — Change In Payable: -9033000.00
AM cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -782000.00
AM cash_flow (annual, 2023-12-31) — Change In Receivables: -1159000.00
AM cash_flow (annual, 2023-12-31) — Change In Tax Payable: 0.00
AM cash_flow (annual, 2023-12-31) — Change In Working Capital: -3982000.00
AM cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -2099000.00
AM cash_flow (annual, 2023-12-31) — Changes In Cash: 66000.00
AM balance_sheet (annual, 2023-12-31) — Common Stock: 4797000.00
AM cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -434846000.00
AM balance_sheet (annual, 2023-12-31) — Common Stock Equity: 2151731000.00
AM cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
AM balance_sheet (annual, 2023-12-31) — Construction In Progress: 192852000.00
AM income_statement (annual, 2023-12-31) — Cost Of Revenue: 419896000.00
AM balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 74109000.00
AM balance_sheet (annual, 2023-12-31) — Current Assets: 91128000.00
AM balance_sheet (annual, 2023-12-31) — Current Liabilities: 96417000.00
AM cash_flow (annual, 2023-12-31) — Deferred Income Tax: 134664000.00
AM cash_flow (annual, 2023-12-31) — Deferred Tax: 134664000.00
AM cash_flow (annual, 2023-12-31) — Depreciation: 136059000.00
AM cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 206731000.00
AM cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 206731000.00
AM income_statement (annual, 2023-12-31) — Diluted Average Shares: 482372000.00
AM income_statement (annual, 2023-12-31) — Diluted EPS: 0.77
AM income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 371236000.00
AM cash_flow (annual, 2023-12-31) — Dividend Received Cfo: 131835000.00
AM income_statement (annual, 2023-12-31) — EBIT: 717318000.00
AM income_statement (annual, 2023-12-31) — EBITDA: 924049000.00
AM income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 105456000.00
AM cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: -105456000.00
AM cash_flow (annual, 2023-12-31) — End Cash Position: 66000.00
AM cash_flow (annual, 2023-12-31) — Financing Cash Flow: -595791000.00
AM cash_flow (annual, 2023-12-31) — Free Cash Flow: 595064000.00
AM cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
AM income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 0.00